Page last updated: 2024-10-31

metoprolol and Infant, Small for Gestational Age

metoprolol has been researched along with Infant, Small for Gestational Age in 3 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.

Research Excerpts

ExcerptRelevanceReference
"We found a five-fold increased risk of delivering a small-for-gestational-age infant in women with heart disease treated with a high dose of beta-blocker, and a two-fold increased risk among those treated with a low dose, showing an apparent dose-response relation."1.72Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease. ( Estensen, ME; Haualand, R; Langesaeter, E; Letting, AS; Sørbye, IK; Wiull, H, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Sørbye, IK1
Haualand, R1
Wiull, H1
Letting, AS1
Langesaeter, E1
Estensen, ME1
Kayser, A1
Beck, E1
Hoeltzenbein, M1
Zinke, S1
Meister, R1
Weber-Schoendorfer, C1
Schaefer, C1
Duan, L1
Ng, A1
Chen, W1
Spencer, HT1
Lee, MS1

Other Studies

3 other studies available for metoprolol and Infant, Small for Gestational Age

ArticleYear
Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease.
    Acta obstetricia et gynecologica Scandinavica, 2022, Volume: 101, Issue:7

    Topics: Female; Fetal Development; Fetal Growth Retardation; Heart Diseases; Humans; Infant; Infant, Newborn

2022
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
    Journal of hypertension, 2020, Volume: 38, Issue:2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Birth Weight; Bisoprolol; Cohort Studies; Fema

2020
Beta-blocker subtypes and risk of low birth weight in newborns.
    Journal of clinical hypertension (Greenwich, Conn.), 2018, Volume: 20, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Fem

2018